期刊
JOURNAL OF NATURAL PRODUCTS
卷 81, 期 1, 页码 178-187出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jnatprod.7b00859
关键词
-
资金
- National Natural Science Foundation of China [81273414]
- CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-2-002]
- Chinese National S&T Special Project on Major New Drug Innovation [2017ZX09101003-007-002, 2015ZX09304006-016]
- PUMC Youth Fund [3332016062]
Analysis of the whole genome sequence of Streptomyces sp. IMB7-145 revealed the presence of seven type I polyketide synthase biosynthetic gene clusters, one of which was highly homologous to the biosynthetic gene cluster of azalomycin F. Detailed bioinformatic analysis of the modular organization of the PKS gene suggested that this gene is responsible for niphimycin biosynthesis. Guided by genomic analysis, a large-scale cultivation ultimately led to the discovery and characterization of four new niphimycin congeners, namely, niphimycins C-E (1-3) and 17-O-methyl-niphimycin (4). The configurations of most stereocenters of niphimycins have not been determined to date. In the present study, the relative configurations were elucidated by spectroscopic analysis, including J-based analysis and the CNMR database method. Further, the full absolute configurations of niphimycins were completely proposed for the first time based on biosynthetic gene cluster analysis of the ketoreductase and enoylreductase domains for hydroxy- and methyl-bearing stereocenters. Compounds 1, 3, 4, and niphimycin I alpha (5) showed antimicrobial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci (MIC: 8-64 mu g/mL), as well as cytotoxicity against the human HeLa cancer cell line (IC50: 3.0-9.0 mu M). In addition, compounds 1 and 5 displayed significant activity against several Mycobacterium tuberculosis clinical isolates (MIC: 4-32 mu g/mL).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据